0000000001301236

AUTHOR

S. Kato

showing 6 related works from this author

Dielectric response of BaTiO electronic states under AC fields via microsecond time-resolved X-ray absorption spectroscopy

2021

This research was performed under the approval of the Photon Factory Program Advisory Committee (PF-PAC; Contract Numbers 2015G580, 2017G587, and 2019G614) and was financially supported by JSPS KAKENHI Grant Numbers 18H01153 , 19H02426 , and 18K19126 . The experiment for measuring spectra in Fig. 6 (b) was performed on beamline BM26A (proposal MA 2731) at the European Synchrotron Radiation Facility (ESRF), Grenoble, France. We are grateful to Local Contact at the ESRF for providing assistance in using beamline BM26A. Institute of Solid State Physics, University of Latvia as the Center of Excellence has received funding from the European Union’s Horizon 2020 Framework Programme H2020-WIDESPRE…

Electronic structureFerroelectricity:NATURAL SCIENCES:Physics [Research Subject Categories]Electrical propertiesExternal electric fieldX-ray absorption spectroscopy
researchProduct

A Phase 2 Trial of Ixabepilone in Asian Patients with Advanced Gastric Cancer Previously Treated with Fluoropyrimidine-Based Chemotherapy

2012

ABSTRACT Background The highest rates of gastric cancer occur in Eastern Asia. Fluoropyrimidine-based therapy is used initially in unresectable and metastatic disease, following progression, 60–70% of patients in Asian countries subsequently receive second-line chemotherapy. However, there is no standard treatment in this setting. Ixabepilone, an epothilone B analog, is a non-taxane microtubule-stabilizing agent with clinical anti-tumor activity across multiple tumor types. We evaluated the efficacy and safety of single-agent ixabepilone as a second-line chemotherapy in Asian patients. Methods Asian patients with unresectable or metastatic gastric adenocarcinoma who had failed previous fluo…

medicine.medical_specialtyChemotherapybusiness.industryStandard treatmentmedicine.medical_treatmentIxabepiloneCancerHematologyNeutropeniamedicine.diseaseGastroenterologychemistry.chemical_compoundOncologychemistryStatistical significanceInternal medicineClinical endpointMedicinebusinessFebrile neutropeniaAnnals of Oncology
researchProduct

CCDC 699927: Experimental Crystal Structure Determination

2009

Related Article: J.Tsutsumi, T.Sasamori, H.Yoshida, N.Tokitoh, N.Sato, S.Kato, I.Muzikante, O.Neilands|2009|J.Mol.Struct.|920|52|doi:10.1016/j.molstruc.2008.10.021

1-Oxo-2-(1-pyridiniumyl)-1H-inden-3-olateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 699925: Experimental Crystal Structure Determination

2009

Related Article: J.Tsutsumi, T.Sasamori, H.Yoshida, N.Tokitoh, N.Sato, S.Kato, I.Muzikante, O.Neilands|2009|J.Mol.Struct.|920|52|doi:10.1016/j.molstruc.2008.10.021

Space GroupCrystallographyCrystal SystemCrystal Structure5-Oxo-6-(1-pyridiniumyl)-5H-cyclopenta[b]pyridin-7-olateCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 699924: Experimental Crystal Structure Determination

2009

Related Article: J.Tsutsumi, T.Sasamori, H.Yoshida, N.Tokitoh, N.Sato, S.Kato, I.Muzikante, O.Neilands|2009|J.Mol.Struct.|920|52|doi:10.1016/j.molstruc.2008.10.021

Space GroupCrystallography5-Oxo-6-(1-pyridiniumyl)-5H-cyclopenta[c]pyridin-7-olateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 699926: Experimental Crystal Structure Determination

2009

Related Article: J.Tsutsumi, T.Sasamori, H.Yoshida, N.Tokitoh, N.Sato, S.Kato, I.Muzikante, O.Neilands|2009|J.Mol.Struct.|920|52|doi:10.1016/j.molstruc.2008.10.021

Space GroupCrystallography5-Oxo-6-(1-pyridiniumyl)-5H-cyclopenta[c]pyridin-7-olateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct